AdvaCare is a CE, ISO and USFDA manufacturer of DengueTest Kits.
Dengue test kits are used for early dengue diagnosis by detection of dengue virus NS1 antigen and immunoglobulin M (IgM)/IgG antibodies in human whole blood, serum, or plasma. These kits were designed based on the principle that when a specimen is added to the sample well, anti-dengue IgG and IgM in the specimen will react with recombinant dengue virus envelope proteins-colloidal gold conjugates and forms a complex of antibodies-antigen.
The test will take approximately 20 minutes to provide a result.
In the case of a positive result, one should consult with their doctor to consider the first stage of treatment. The dengue test has been shown to be accurate in 98% of cases, clearly demonstrating its reliability.
Dengue fever is a painful and debilitating Dengue mosquito-borne disease caused by any one of four closely related dengue viruses. These viruses are related to the viruses that cause West Nile infection and yellow fever. The tropical disease is transmitted by the Aedes aegypti mosquito causing a range of mild to severe symptoms. The basic symptoms include a high fever, headaches, pain behind the eyes, joint and muscle pain, nausea, vomiting, skin rash and mild nosebleeds.
As, the disease progresses dengue leads to hemorrhagic fever, a rare complication characterized by high fever, damage to lymph and blood vessels, bleeding from the nose and gums, enlargement of the liver, and failure of the circulatory system. The symptoms may progress to massive bleeding, shock, and death, this is called dengue shock syndrome (DSS).
There is no vaccine to prevent dengue fever. The best way to prevent the disease is to prevent bites by infected mosquitoes, particularly if you are living in or traveling to a tropical area. This involves protecting yourself and making efforts to keep the mosquito population down, for example, using mosquito repellant, wearing long-sleeved clothes and using mosquito nets. An indirect method of by removing breeding opportunities such as stagnant water bodies found in cans and flower pots.
Individuals with weakened immune systems are at greater risk i.e. HIV positive patients.
An estimated 390 million dengue infections occur worldwide each year, with about 96 million resulting in illness. Most cases occur in tropical areas of the world, with the greatest risk occurring in The Indian subcontinent, Southeast Asia, Southern China, Taiwan, Pacific Islands; The Caribbean (except Cuba and the Cayman Islands); Mexico; Africa; Central and South America (except Chile, Paraguay, and Argentina).